January 19, 2016
Banville Law reports on a recent surge in lawsuits filed against various manufacturers of laparoscopic power morcellator devices, all of which similarly claim that the devices can disseminate and accelerate uterine sarcoma cells while shredding uterine fibroids during gynecological surgeries such as hysterectomies and myomectomies.
Manufacturers named in the various lawsuits include Ethicon (a division of well-known Johnson & Johnson corporation), Lumenis Ltd., Olympus, Richard Wolf GmbH, Cook Urological Inc., Karl Storz GmbH, Blue Endo, Smith & Nephew, and LiNA Medical. Complaints that were filed against Ethicon have been consolidated by the U.S. Judicial Panel on Multidistrict Litigation to form MDL No. 2652.
In 2014, The U.S. Food and Drug Administration issued a safety warning which discussed power morcellation procedures, and indicated that women were to refrain from undergoing the procedure if it involved uterine fibroids due to a risk of spreading previously undetected cancer cells. Additionally, the FDA estimated that 1 out of every 350 women who undergo these gynecological surgeries today may have hidden sarcomas which they are completely unaware of. If cancer cells are encapsulated within a uterine fibroid, they are virtually undetectable before surgery.
They attorneys at Banville Law understand the seriousness of this issue and the devastation a cancer diagnosis can cause. They are working to ensure that anyone who has undergone this procedure and who was later diagnosed with cancer will have an opportunity to explore their legal rights. These women may be entitled to significant compensation. The attorneys at Banville Law are currently offering free legal consultations for anyone affected.
To ask request additional information on power morcellation lawsuits, or ask questions, please contact the attorneys at Banville Law by calling (888) 997-3792.